Mouse thymocytes were used to compare mechanisms by which Vibrio cholerae and heat-labile Escherichia coli enterotoxins activate the adenylate cyclase-cyclic adenosine monophosphate (AMP) system. Both enterotoxins had their time-delayed increase in cyclic AMP neutralized by antisera to V. cholerae or E. coli enterotoxin, blocked by low concentrations of ganglioside GMI, and destroyed by prior heating. Enterotoxin activation of adenylate cyclase was similarly affected. By contrast, prostaglandin E,-mediated increases in cyclic AMP were not affected by specific antitoxins or gangliosides. Combination of maximal stimulatory doses of both enterotoxins did not produce additive increases in cyclic AMP. Wash experiments suggested that both enterotoxins bind rapidly and tightly to thymocytes at 37 C. However, lowering the incubation temperature to 8 C reduced the affinity of E. coli enterotoxin but not cholera toxin for thymocytes. Results suggest that heat-labile E. coli enterotoxin and cholera enterotoxin may activate the same adenylate cyclase enzyme by similar mechanisms.
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Enterotoxins produced by pathogenic strains of Escherichia coli are now recognized as a probable cause of acute diarrhea in infants (11) , adults (25) , and animals (15) . These enterotoxins can be either heat-stable or heat labile (8) . Heat-labile E. coli enterotoxin (ECT) has been shown to be antigenically related to cholera toxin (CT) (14, 26) and may act via the adenylate cyclase-cyclic adenosine monophosphate (AMP) system like CT (7, 13, 19) . However, major differences between the action of ECT and CT concerning onset (24) and duration (24) have been shown. In addition, certain experiments have suggested that the receptor sites for ECT and CT may be different (16) . Therefore, a considerable amount of uncertainty as to the actual mechanisms of ECT action now exists.
The action of CT has been extensively studied in skin (16) , gut (16, 20, 21) , fat (6) , and lymphatic (3, 4, 17) cells. Although the gut is the natural site of CT action, CT elicited a delayed activation of adenylate cyclase (3, 4, 20, 21) and was specifically inhibited by ganglioside GM, (6, 16, 17) in every tissue or cell type studied. In lymphocytes, the action of CT on the adenylate cyclase-cyclic AMP system is distinct from that of prostaglandin (PG) E, (3) . Accordingly, we have attempted to compare the action of partially purified heat-labile ECT to the well-studied and diverse actions of PGE, and purified CT on thymocytes in the hopes of gaining a better understanding of the cellular and molecular mechanisms of heat-labile ECT action.
MATERIALS AND METHODS Materials. E. coli strain 408-3 (serotype 078: H12) was isolated from the gastrointestinal tract of a patient with severe cholera-like diarrhea in Calcutta (25) Preparation and assay of adenylate cyclase. After incubating thymocytes (20 ml) at 37 C for 60 min with test agents, three 0.5-ml portions were taken from each group for cyclic AMP determination and the remaining cells were pelleted by centrifugation. The cell pellet was resuspended in 10 ml of cold 10 mM tris(hydroxymethyl)aminomethane-hydrochloride, pH 7.6, 2.0 mM MgSO4, 0.5 mM ethylenediaminetetraacetic acid, and 1.0 mM dithiothreitol. All subsequent tissue processing steps were performed at 4 C. The cells were gently homogenized. After ad-INFECT. IMMUNITY justing the volume to 30 ml, the homogenate was passed through four layers of gauze and centrifuged at 3,000 x g for 10 min. The 3,000 x g pellet was resuspended and homogenized by hand in 0.5 ml of buffer.
The incubation mixture for determining adenylate cyclase activity was the same as previously described (29) . The reaction was initiated by addition of the 3,000 x g fraction (60 to 100 gg of protein) and was linear for 5 min at 30 C. The cyclic AMP formed was isolated and determined by the method of White and Zenser (28) . Adenylate cyclase activity is expressed as picomoles of cyclic AMP formed per milligram of protein per 5 min. Using these assay conditions, cyclic phosphodiesterase activity, determined as described by Thompson and Appleman (27) , was not detectable in the washed 3,000 x g pellet. Six determinations of each condition were made.
RESULTS
Effect of enterotoxin concentration and incubation time on cyclic AMP accumulation in thymocytes. A 15-to 20-min delay preceded the increase in cyclic AMP mediated by both enterotoxins, whereas PGEl elevated cyclic AMP levels 10-fold higher than basal within 3 min (Fig. 1) . Maximal responses were at 10 min for PGE, and at 30 min for both enterotoxins.
The latter time was therefore chosen as the optimal incubation time in the experiments to follow. Cyclic AMP levels were still elevated 3 h after addition of these agents. As previously shown for CT, the delay period preceding activation by ECT was independent of enterotoxin concentration with either 16 ECT elicited a dose-dependent increase in cyclic AMP (Fig. 2) . The lowest effective stimulatory concentration of purified ECT was between 0.5 and 1 jig of enterotoxin protein per ml.
By contrast, the lowest effective stimulatory concentration of CT was 3 ng/ml. Maximal ECT stimulation was achieved at approximately 16 ug/ml. Maximal doses of both enterotoxins heated at 95 C for 20 min were nonstimulatory.
Inactivation of enterotoxins by specific antitoxins. Preincubation of CT with V. cholerae antitoxin completely blocked the CTinduced accumulation of thymocyte cyclic AMP at a 10-4 dilution (Fig. 3) . In addition, ECT-induced accumulation of cyclic AMP was completely blocked at a 10-3 dilution of antitoxin. E. coli antitoxin was much more effective in blocking the ECT-than CT-induced accumulation of cyclic AMP. Although a 10-3 dilution completely blocked the ECT response, only at 10-I dilution was effective in blocking CT. Neither antitoxin modified the basal cyclic AMP level or the increase mediated by PGE,.
By using the rabbit ileal loop assay, we were also able to neutralize ECT with either antitoxin.
Inactivation of enterotoxins by specific gangliosides. Using purified gangliosides and submaximal concentrations of CT and ECT of similar potencies, we investigated the ability of gangliosides to inhibit enterotoxin action (Fig.  4) . The order and approximate concentrations of ganglioside required to obtain half-maximal inhibition for CT are: GM1, 0.002 jig/ml; GDla, 0.010 ,ug/ml; GM2, 3 jg/ml; and GTX, 20 jg/ml.
For ECT the values are: GMI, 0.006 ,g/ml; GDlM, 0.032 jg/ml; GM2, 3.5 jg/ml; and GTX, 14 jig/ml. Approximately five molecules of GM, were required to completely neutralize one molecule of CT. Gangliosides had no influence on the basal or PGE,-stimulated cyclic AMP levels.
The effect of gangliosides on thymocyte adenylate cyclase activity was also examined (Fig.  5) . Addition of gangliosides to control cells during a 60-min incubation did not effect adenylate cyclase activity or cyclic AMP content. By contrast, gangliosides blocked the increase in adenylate cyclase activity and cyclic AMP content in enterotoxin-treated cells. Addition of CT or ECT to the homogenized 3,000 x g thymocyte pellet for periods up to 40 min failed to stimulate adenylate cyclase activity, whereas PGE1 caused an immediate increase in activity.
Interaction of enterotoxins with thymocytes. As shown above and also in Fig. 6 , preincubation of enterotoxins with gangliosides for 20 min completely blocked the toxininduced increase in cyclic AMP. Although the amount of bovine brain gangliosides used (Fig.  6 ) was 10-fold greater than the amount re-VOL. 10 When present, bovine brain gangliosides type II were at a final concentration of 5 ug/ml. At the -20-min designation on the abscissa, enterotoxins and gangliosides were mixed for 20 min at 24 C before addition to thymocytes. (13) in canine intestine but is consistent with a recent report by Kantor et al. (19) , where adenylate cyclase activity was assessed in rabbit small intestine. The rapid rise in cyclic AMP levels followed by a sharp decline has also been shown by Boyle and Gardner (4) . Essentially the same time course of enterotoxin activation was obtained when the total cyclic AMP content of the incubation mixture was determined. Combining maximal stimulatory doses of both enterotoxins failed to produce additive increases in cyclic AMP, which suggests these enterotoxins activate the same adenylate cyclase enzyme.
Identification of the cell membrane receptor for CT has been extensively investigated. Cuatrecasas working with rat liver membranes (5) and fat cells (6) and Holmgren with intestine (16) , skin (16) , and thymocytes (17) have demonstrated that ganglioside GM1 was the most effective ganglioside in neutralizing CT action. Furthermore, Holmgren (16) showed that GM1 was much more effective than other gangliosides in neutralizing ECT. Accordingly, this ganglioside was more effective than GDlaI GM2, or GT1 in inhibiting CT-and ECT-induced accumulation of thymocyte cyclic AMP. The inhibition which was seen at only high concentrations of GM2 or GT1 may have been due to VOL. 10, 1974 contaminating amounts of GM1 since these gangliosides were not 100% pure. Comparison of half-maximal inhibition data for both toxins shows that the concentrations of the gangliosides required to neutralize concentrations of ECT and CT of similar potency were similar. Gangliosides had no detectable effect on basal cyclic AMP levels or PGE1 stimulation. These observations imply that GM l may be part of the cellular receptors for ECT as well as for CT.
By contrast, Holmgren (16) suggests that GM1 is not the membrane receptor for ECT, since much higher concentrations of gangliosides GM, were required to inhibit the action of ECT than CT. Factors possibly responsible for this discrepancy are differences in the action of porcine and human ECT, in assay, and in the ECT preparation. The amount of incubation time required to monitor enterotoxin activity was also an important variable. In this regard, Cuatrecasas (6) has shown that incubation of CT and gangliosides with fat cells for more than 2 h can result in increased expression rather than inhibition of toxin action. This phenomenon was explained by the ability of gangliosides to become incorporated in fat cell membranes in a manner that permitted them to act as additional binding sites for CT. Since ECT appears to act in a more or less similar manner to CT, biological assays requiring long incubations, as employed by Holmgren, may not be appropriate methods of studying these interactions. In the present study, the 30-min incubation period required for toxin assay was apparently too brief for incorporation of gangliosides into the cell membrane as receptors. In the sorbent assay performed by Holmgren (16) , differences in affinity of CT and ECT for GM1 were much less than that found in the skin or ileal loop assay and similar to those in this study. However, since results were expressed in dry weight rather than in milligrams of protein, comparison is difficult. The ability of choleragenoid to block the action of CT but not ECT (16, 23) (12) and human leukocytes (3) but has little effect on CT binding even at low temperatures (3, 17) . Accordingly, thymocytes treated with PGE, for 5 min could be completely separated from this stimulator by washing. By contrast, enterotoxin activity was not removed even after extensive washing. Lowering the temperature has little effect on CT activity. However, considerably less ECT activity remained with thymocytes washed after incubation at 8 rather than 37 C. Qualitatively, it appears that both ECT and CT bind rapidly and tightly to thymocytes, producing a delayed activation of adenylate cyclase, and that the affinity of CT for thymocytes may be greater than ECT. Final verification of these observations await purification of ECT.
